首页|静脉注射吴茱萸碱-甘草酸纳米胶束后吴茱萸碱在大鼠体内药代动力学研究

静脉注射吴茱萸碱-甘草酸纳米胶束后吴茱萸碱在大鼠体内药代动力学研究

扫码查看
目的 建立高效液相色谱法(HPLC)测定大鼠血浆中的吴茱萸碱,研究大鼠尾静脉注射吴茱萸碱-甘草酸纳米胶束后的药代动力学情况.方法 大鼠尾静脉注射吴茱萸碱-甘草酸纳米胶束和吴茱萸碱溶液后,采用HPLC测定大鼠血浆中吴茱萸碱的含量,绘制血药浓度-时间曲线,以DAS2.0软件分析处理药代动力学参数.结果 吴茱萸碱-甘草酸纳米胶束和吴茱萸溶液的Cmax分别为(1.61±0.19)和(0.92±0.11)μg·mL-1,AUC0~t 分别为(4.76±1.41)和(2.07±0.22)mg·L-1·h,CL分别为(0.67±0.21)和(1.38±0.14)L·h-1·kg-1,吴茱萸碱-甘草酸纳米胶束的Cmax、AUC0~t较吴茱萸碱溶液提高了 1.75、2.30倍,CL是吴茱萸碱溶液的0.48倍,Cmax、AUC0~t和CL差异均有统计学意义(P<0.05).结论 将吴茱萸碱制备为吴茱萸碱-甘草酸纳米胶束能延长吴茱萸碱在体内的作用时间,延缓吴茱萸碱在体内的代谢.
In vivo pharmacokinetics of evodiamine in rats after intravenous injection of evodiamine-glycyrrhizic acid micelles
Objective To establish an HPLC method to determine evodiamine in rat plasma and to study the intravenous pharmacokinetics of evodiamine-glycyrrhizic acid micelles in rats.Methods The rats were administerted evodiamine-glycyrrhizic acid micelles and evodiamine solution,respectively.The content of evodiamine in the rat plasma was determined by HPLC,and the pharmacokinetic parameters were analyzed by DAS 2.0 software.Results The Cmax of evodiamine-glycyrrhizic acid micelles and evodiamine solution was(1.61±0.19)and(0.92±0.11)μg·mL-1;AUC0~t was(4.76±1.41)and(2.07±0.22)mg·L-1·h;CL was(0.67±0.21)and(1.38±0.14)L·h-1·kg-1,respectively.The Cmax and AUC0~t were 1.75 and 2.30 times higher than those of evodiamine solution,while CL was 0.48 times higher than that of evodiamine solution.The difference in Cmax,AUC0~t and CL was significant(P<0.05).Conclusion The conversion of evodiamine into micelles with glycyrrhizic acid may prolong the duration and metabolic processes of evodiamine in vivo.

evodiamineglycyrrhizic acidmicellepharmacokinetics

邓英光、银雪艳、郭秀彩、张紫萍、李峰

展开 >

广州市第十二人民医院,广州 510620

吴茱萸碱 甘草酸 胶束 药代动力学

广东省中医药局中医药科研项目

20222154

2024

中南药学
湖南省药学会

中南药学

CSTPCD
影响因子:0.736
ISSN:1672-2981
年,卷(期):2024.22(1)
  • 5